Blood test could flag COVID patients needing ventilators
NCT ID NCT07466524
Summary
This study looked back at data from 500 U.S. adults hospitalized with COVID-19. Researchers tested whether a specific blood marker (suPAR) measured early in a hospital stay could predict which patients would develop severe breathing failure needing a ventilator within 30 days. The goal was to validate this test for use in diverse U.S. patient populations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michigan state university, Department of Biostatistics
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.